Buyer for CDMO company in Germany

Company to buy

• Size: Small to mid-size business
• Sales: 10 – 35 million EUR
• Location: Germany
• Reason for acquisition: The management wants to expand its business
• #CFIE PHB242

Overview of buyer for CDMO company in Germany

The company was established about 15 years ago with a dedication to excellence. Since then, it has carved a niche by offering comprehensive, tailor-made solutions across the entire drug development spectrum. In particular, the buyer company is interested in a manufacturing target. Further, having a positive EBITDA is seen as an advantageous characteristic.

Profile (strategy) of buyer for CDMO company in Germany

The company arose from the realization that the potential of low-solubility drugs, which are often crucial for combating prevalent chronic diseases, was unjustly locked away by their resistance to dissolve in water. Fueled by a mission to bridge this critical gap, the company embarked on a journey to transform a scientific possibility into tangible patient benefit.

Over the years, the company has blossomed into a leading force in the pharmaceutical landscape, guided by a team of dedicated scientists and formulation specialists. Altogether, their combined expertise and unwavering curiosity have cemented the company as a comprehensive solution for low-solubility drug development and manufacturing.

Primarily, the company recognizes that medication should not only heal but also enhance the patient experience. Thus, their focus on developing innovative dosage forms, like disintegrating tablets and taste-masked suspensions, improves compliance and quality of life for those battling chronic conditions.

Today, the company stands as a recognized leader in tackling the challenge of low-solubility drugs. Overall, the company offers a comprehensive range of services encompassing pre-formulation development, pilot-scale, and commercial manufacturing. Moreover, it supports pharmaceutical companies from concept to market.

Activities and products of suitable targets

Essentially, the target company should have an excellent status in Germany, reflecting a commitment to quality and rigorous standards.

They are specifically interested in companies specializing in developing and manufacturing oral dosage forms for low-solubility drugs. Preferably with spray drying and hot melt extrusion capabilities. Most importantly, the desired company should have a strong background in pharmaceutical research, development, manufacturing, and distribution.

The buyer is also looking for a target company with market expansion potential, including the ability to penetrate new markets, forge strategic partnerships, and explore growth opportunities.

Additionally, a positive EBITDA performance would be advantageous, indicating a healthy financial performance, profitability, and a sustainable business model.

Highlights

• More than 15 years of history
• Pioneers in unlocking the potential of poorly soluble drugs, crucial for many chronic diseases
• Transforming scientific potential into patient benefit through cutting-edge technologies like spray drying and hot melt extrusion
• Leading force in the pharmaceutical landscape
• Revolutionizing oral dosage
• Strong intellectual property

More information on this buyer for CDMO company in Germany

Please get in touch if you are interested in learning more about this buyer for CDMO company in Germany. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.